Skip to main content
PLOS One logoLink to PLOS One
. 2025 Mar 28;20(3):e0319571. doi: 10.1371/journal.pone.0319571

Prevalence and determinants of depression and/or anxiety among adults using Kenya Demographic and Health Survey of 2022: Multilevel logistic regression analysis

Mamaru Melkam 1,*, Setegn Fentahun 1, Girmaw Medfu Takelle 1, Gidey Rtbey 1, Fantahun Andualem 1, Girum Nakie 1, Gebresilassie Tadesse 1, Yilkal Abebaw Wassie 2
Editor: Kamalakar Surineni,3
PMCID: PMC11952211  PMID: 40153452

Abstract

Introduction

Depression and/or anxiety can be persistent or recurrent significantly affecting a person’s capacity to manage daily life, job, and school. The burden of depression and anxiety is rising from time to time, with serious consequences for overall health. Depression and anxiety are crippling conditions that can impact individuals of the whole community. Despite the high prevalence of depression and/or anxiety few studies were conducted that show the diagnosis levels of depression and/or anxiety in the community, particularly in Kenya. Therefore, this study aims to determine the prevalence of depression and/or anxiety and their determinant factors among adults in Kenya using data sourced from the 2022 Kenya Demographic and Health Survey.

Method

The Kenya demographic and health survey of 2022 data were used for this secondary data analysis in 2024. The survey included age groups ranging from 15 to 49, with a total sample size of 16,901 participants. Multilevel analysis was used to determine the prevalence of depression and/or anxiety with determinant factors at the 95% CI.

Results

The overall prevalence of depression and/or anxiety was 3.84% with a 95% CI of (3.56, 4.14). Of this, 2.85% have only depression, 1.97% have only anxiety disorders, and 0.98% have comorbid depression and anxiety. In multivariable multilevel logistic regression analysis sexually violated, having a chronic medical illness, being divorced and widowed, having a job, and being HIV positive were associated with depression and/or anxiety with a p-value of less than 0.05.

Conclusions

According to the findings of this study the prevalence of depression and/or anxiety was 3.84%. This finding poses a significant challenge for the community to perform their daily tasks. As a result, the healthcare systems of Kenya have to mitigate the burden of depression and/or anxiety. All the clients must be treated since they received a diagnosis as reported by the physician.

Introduction

Depressive disorders are characterized by loss of interest or pleasure, depressed mood, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, suicide, and poor concentration [1]. Anxiety can be defined as feelings of tension, uneasiness, nervousness, fear, and high autonomic activity with varying degrees of intensity and excessive wornness with a catastrophic future [2]. According to the Diagnostic and Statistical Manual-V (DSM-V) anxiety disorders refer to a group of mental disorders characterized by feelings of anxiety and fear, including generalized anxiety disorder, panic disorder, phobias, social anxiety disorder, and anxiety secondary to medical conditions and substance use [2]. Depression and anxiety share common clinical features including; fatigue or loss of energy, difficulty in concentration, psychomotor disturbance, and disturbed sleep or appetite [3].

According to a World Health Organization (WHO) report, depression and anxiety are the most common disorders among other mental illnesses worldwide [4]. They are the most significant health indicators that contribute significantly to morbidity in mental health. A 2008 WHO survey stated that one in five persons had experienced depression and anxiety in the previous year and that 29.2% had encountered mental disease at some point in their lives [5]. Depression and anxiety are the most common mental health disorders in the community due to their devastating impact on serious public health problems with a recent global burden of 4.4%[1,6]. Depression is a prevalent mental health condition that impacts over 300 million individuals globally [1]. In the world in 2013, one in nine individuals suffered from an anxiety disorder [7]. The worldwide projected percentage of the world’s population suffering from anxiety disorders in 2015 was 3.6%, which is more common among females than males (4.6% compared to 2.6% at the global level) [1].

According to a recent study, there are huge variations in the prevalence of depression and anxiety from place to place based on the cultural and geographic context [8]. It can also aid in the planning of community-based preventive initiatives and the allocation of public health and clinical treatment resources to populations that most need them [9]. An estimated 300 million individuals worldwide or 4.4% of the global population are thought to suffer from depression. Anxiety and depression frequently prevent people from engaging in daily activities, such as caring for their families or working efficiently [10]. In the China population survey study the burden of comorbid depression and anxiety was 9.05% with 10.6% depression and 12.8% anxiety [11]. The comorbid prevalence of depression and anxiety was 2% in the New York community [12]. In Australia, the prevalence of depression and anxiety at the community level was 10% [13]. The prevalence of depression among adults ranges between 11.4–39.6% [1418] while the incidence of anxiety is between 14.2–37.7% [18]. The prevalence of depression and anxiety in Malaysia was 12.3% and in Pakistan, a systematic review and meta-analysis on depression and anxiety revealed 34% [17,19]. In Ghana, a community-based study the prevalence of depression and anxiety was 24.2% [20]. The prevalence of depression and anxiety in low and middle-income countries was 2.3% [21]. The prevalence of depression and anxiety in Ethiopia was 10.04% [22] Somalia and Kenya refugees were 33.6% [23].

From the previous studies, there are a lot of factors that were associated with depression and/or anxiety including; female sex, age, marital status, having a diagnosed chronic noncommunicable medical diseases and alcohol consumption, mass media exposure, and low income the most statistically important [19,20,24]. Education level, employment status, living conditions, hypertension, use of cigarettes, physical inactivity, and sexual violence were also other factors that were associated with depression and/or anxiety [18,2527]. Not being treated and physically inactive/or not doing exercise were also the most determinant significant factors for anxiety and depression [28, 29].

Even though there is a large burden of depression and anxiety at the community level, there are no studies conducted in Kenya at the community level. Depression and anxiety are the most important mental disorders that need great attention and priority to mitigate the magnitude and risk factors, especially in low and middle-income countries including Kenya. To have effective interventions for common mental problems particularly, depression and anxiety this study will give evidence for prevention, intervention, and policy-makers from KDHS (Kenya Demographic and Health Survey). The prevalence of depression and anxiety are conducted in different populations among medical clients, students, and immigrants assessed with screening tools rather than diagnostic levels [22,30,31]. Depression and anxiety are not conducted at the level of diagnostic levels which means this study revealed the participants who have leveled as they have depression and anxiety by physician at the community survey level. With these considerations, this study aims to determine the prevalence and determinant factors of depression and/or anxiety among adults in Kenya based on Demographic and Health Survey data of 2022.

Methods and materials

Study design, setting, and participants

Community-based multilevel secondary data analysis was employed in 2024, from the 2022 Kenya Demographic and Health Survey (KDHS). This study was conducted from the Kenya Demographic Health Survey data of 2022 from Kenya. KDHS is the seventh survey conducted in Kenya. A two-stage stratified sampling design was used for the Kenya Demographic and Health Survey (KDHS) in 2022. Using the equal probability selection method, 1,692 clusters were chosen in the first stage from the Kenya household health survey framework. The survey included men, women, children, births, and households’ datasets from the KDHS. From this survey, the extracted data was the Individual Record dataset (IR file). Men and women participants between the ages of 15 to 49 were selected from the Kenya community as the source of populations. A total of 16,901 weighted samples were used as a final analysis for this study from the clusters. Detailed information can be accessed from this official dataset link http://www.dhsprogram.com/.

Measurement variables of the study

Dependent variables.

The outcome variables were measured by the diagnostic criteria and participants were leveled as having depression and anxiety rather than using screening tools. Told by a doctor they have the diagnosis of depression and anxiety were taken with assessment done by physicians’ diagnosis criteria. The outcomes are not assessed by screening material or tools to identify participants who have depression and anxiety rather participants are leveled by doctors as they have depression and anxiety. The diagnosis of the two disorders is generated as a single variable and positive either for depression and/or anxiety were coded 1 and the otherwise 0. Therefore, the dependent variable was used from the KDHS definitions as reported in 2022.

Independent variables.

Educational level, age, marital status, sex, religion, ethnicity, current use of cigarettes and alcohol, wealth status, occupations, and residence were included as sociodemographic variables. Sexual violence, chronic medical illness (having at least one of the following diseases; DM, hypertension, and heart disease), HIV positive, and physical exercise were considered as the clinical and behavioral variables extracted from the KDHS based on the literature review conducted previously in depression and anxiety. Mass media exposure and residence were considered for community-level variables in this study.

Data management and analysis.

The extracted Kenya DHS data have sociodemographic, behavioral, and clinical characteristics. The extracted data was cleaned and recorded for further analysis with Stata version 14. The descriptive statistics including frequency and percentage were done in text and table. To maintain the hierarchical nature of the extracted data a mixed multilevel analysis was conducted. Variables with a p-value of less than 0.25 from bivariable multilevel logistic regression were selected to be further analyzed in multivariable analysis and p-value less than 0.05 were statistically significantly associated. Adjusted Odd Ratio (AOR) and 95% Confidence Interval (CI) for the associated variables with depression and/or anxiety were employed.

Four model analyses were contracted for multivariable multilevel logistic regression analysis. The first model was a null model or model one conducted without explanatory variables. The second model fitted the individual-level variables only, the third model contained community-level variables, and the fourth model fitted both individual and community-level variables. Deviance and Akaike Information Criterion (AIC), were used for model comparison and fitness, from this analysis having the lowest score was considered the best-fitted model.

Additionally, the random effect of depression and/or anxiety measure of variation across residence clusters was done by Intra Class Correlation (ICC) and Median Odds Ratio (MOR). The degree of homogeneity of depression and/or anxiety measurement, and the variation of depression and/or anxiety in the cluster by odd ratio scale measurement were performed by ICC and MOR respectively [32]. Finally, the AOR with 95% CI was included and factors with p-values less than 0.05 were considered statistically significantly associated.

Ethics approval and consent to participate.

This study did not need ethical clearance since we used secondary data without direct contact with the study participant. The data was obtained from the measure of DHS program and we have received permission to access the data online with a request to the measure DHS program http://www.dhsprogram.com. The data is available online for everyone publicly. The ethical approval detail information authorized to download Survey data from the Demographic and Health Surveys (DHS) Program is accepted.

Results

Descriptive characteristics of the participant

A total of 16,901 study participants between the ages of 15 to 49 were included in this secondary data analysis. Of the study participants, 14453(85.52%) were male. About 5,657(33.47%) were protestant religious followers and more than half of the study participants 10,384(61.44%) were from rural areas. More than half of the study participants were married and more than half of the study participants 9,158(54.24%) had a job (Table 1).

Table 1. Descriptive characteristics of the study participants by socio-demographic and depression and/or anxiety (n = 16,901).

Variables Categories Weighted sample (%) Depression and/or anxiety
Yes No
Sex Male
Female
14453(85.52)
2448(14.48)
554
95
13889
2353
Age 15-19
20-29
30-39
40-49
3339(19.76)
5895(34.88)
4689(27.74)
2978(17.62)
61
208
218
160
3276
5687
4471
2818
Region Catholic
Protestant
Evangelical Church
African instituted church
Islam
Others religions * 
3,005(17.78)
5,657(33.47)
3,581(21.19)
1,298(7.68)
2,637(15.60)
723(4.27)
138
218
141
50
72
30
2867
5439
3440
1248
2565
693
Mass media exposure Yes
No
14253(84.32)
2847(14.48)
354
96
14 607
2943
Educations No Education
Primary
Secondary
Higher
2,075(16.84)
6,171(36.51)
6,067(35.90)
2,588(15.31)
62
253
200
134
2013
5918
5867
2454
Residence Urban
Rural
6,517(38.56)
10,384(61.44)
298
351
6219
10033
Ethnicity Kalenjin
Kamba
Kikuyu
Luhya
Luo
Meru
Somali
Others ethnicity **
3,339(19.76)
1,457(8.62)
2,326(13.76)
2,178(12.89)
2,557(15.13)
1,105(6.54)
1,326(7.85)
2613(15.46)
106
31
105
99
86
50
25
178
3233
1426
2221
2079
2471
1055
1301
2416
Occupations No job
Have job
7,725(45.76)
9,158(54.24)
179
469
7546
8689
Marital status Never in union
Married
Widowed/separated
5,259(31.12)
8,685(51.39)
2,957(17.50)
132
325
192
5127
8360
2765
Wealth index Poorest
Poorer
Middle
Richer
Richest
3,758(22.24)
2,975(17.60)
3,308(19.57)
3,753(22.21)
3,107(18.38)
113
104
133
145
154
3615
2871
3175
3608
2953

*Other religions (Hindu, orthodox, atheist, traditionist).

**Other ethnicity (embu, kisii, maasai, mijikenda/Swahili, taita/taveta).

Clinical and behavioral characteristics of the study

Of the study participants, 15,388(91.05%) had at least one chronic medical illness, and 400(2.37%) of the study participants were declared HIV positive. From the study participants, 15,403(91.14%) were alcohol users almost every day and 1,378(8.15%) had family/parental alcohol conceptions. Almost all the study participants 16,795(99.37%) use cigarettes despite 12,418(73.47%) doing physical exercise. Of the study participants, 488(2.89%) faced sexual violations based on their gender (Table 2).

Table 2. Clinical and behavioral characteristics of the study participants (n = 16901).

Variables Categories Weighted sample (%) Depression and/or anxiety
Yes No
Chronic medical illness Yes
No
15,388(91.05)
1,513(8.95)
471
178
14,917
1,335
HIV positive Yes
No
400(2.37)
16,501(97.63)
35
612
363
15,889
Alcohol use Not at all
1-5 days
6-10 days
11-24 days
Almost every day
818(4.84)
537(3.18)
89(0.53)
54(0.32)
15,403(91.14)
55
55
9
6
524
763
482
80
48
14,879
Family alcohol use Yes
No
1,378(8.15)
15,523(91.85)
104
545
1274
14,978
Cigarette use Yes
No
16,795(99.37)
106(0.63)
639
10
16,156
96
Physical exercise Active
Inactive
12,418(73.47)
4,483(26.53)
488
161
11,930
4322
Sexual violence Violated
Not violated
488(2.89)
16,413(97.11)
62
582
426
15,826

Prevalence of depression and/or anxiety

The overall prevalence of depression and/or anxiety from the KDHS data was 3.84% with a 95% CI of (3.56,4.14). Of this, 2.85% have only depression, 1.97% have only anxiety disorders, and 0.98% have comorbid depression and anxiety. From the overall prevalence 3.85% of depression and/or anxiety 85% were male participants and 15% were female participants.

Model fitness and statistical analysis

The ICC in the null model (model one) was a 21.21% variation of the participants who have depression and/or anxiety related to the attributed to the cluster. The null model’s MOR of depression and/or anxiety was 1.85, suggesting that there was variation amongst the clusters. The odds of a single participant with depression and/or anxiety were 1.85 times higher in the cluster with a higher risk of these conditions than in the cluster with a lower risk, if that person was chosen at random from each of the two clusters. The lowest deviation value was used to select the best fitting; therefore, model IV was the best model for this study (Table 3).

Table 3. Multilevel analysis of variables associated with depression and/or anxiety among DHS of Kenya, 2022.

Variables Null model Model I Model II Model III
Age
15-19 1.00 1.00
20-29 1.08(0.77,1.51) 1.07(0.76, 1.50)
30-39 1.18(0.81, 1.71) 1.17(0.80, 1.70)
40-49 1.13(0.77, 1.67) 1.13(0.76, 1.67)
Cigarette use
No 1.00 1.00
yes 1.80(0.87, 3.71) 1.79(0.87, 3.71)
HIV Positive
No 1.00 1.00
Yes 2.09(1.45, 3.02)*  2.10(1.45, 3.03)
Education
No education 0.87(0.61, 1.22) 0.89(0.63, 1.25)
Primary 0.81(0.63, 1.03) 0.83(0.65, 1.05)
Secondary 0.80(0.63, 1.03) 0.82(0.64, 104)
Higher 1.00 1.00
Marital status
Married 1.00 1.00
Single 0.93(0.72, 1.21) 0.93(0.71, 1.20)
Divorce/widowed 1.39(1.14, 1.69) *  1.38(1.13, 1.67)
Occupation
Haven’t job 1.00 1.00
Have job 1.55(1.27, 1.90) *  1.55(1.26, 1.89)
Sexual violence
Not violated 1.00 1.00
Being violated 2.81(2.05, 3.85) *  2.85(2.05, 3.86)
Family substance use
No 1.00 1.00
Yes 1.20(0.94, 1.54) 1.20(0.94, 1.54)
Chronic medical illness
No 1.00 1.00
Yes 3.50(2.89, 4.23) *  3.49(2.88, 4.22)
Physical exercise
Inactive 1.00 1.00
Active 0.99(0.82, 1.20) 0.99(0.81, 1.19)
Alcohol use
Not drink 1.00 1.00
Drink 1-5 days 1.60(0.07, 2.39) 1.59(0.06, 2.38)
Drink 6-10 days 1.46(0.68, 3.17) 1.46(0.67, 3.16)
Drink 11-24 days 1.54(0.57, 4.15) 1.52(0.56, 4.12)
Drink almost every day 0.70(0.52, 4.95) 0.71(0.52, 4.95)
Community level analysis
Residence
Rural 1.00 1.00
Urban 1.37(1.17, 1.60) 1.17(0.99, 1.39)
Mass media exposure
High
Low
1.48(1.20, 1.72)
1
1.51(0.88, 2.01)
1
Model fit statistics Model I Model II Model III Model IV
Log likely ratio test -2767.27 -2568.14 -2764.79 -2566.68
Deviance 5496.0775 5133.3654 5529.5805 5096.7952
AIC 5179.318 5178.283 5535.581 5177.365
BIC 5437.946 5340.698 5558.786 5337.515
ICC .0212171
MOR 1.85

*ICC: Intra-Class Correlation.

*MOR: Median Odds Ratio.

*AIC: Akaike Information Criterion.

*BIC: Bayesian Information Criteria.

Associated factors with depression and/or anxiety

In bivariable logistic regression analysis age, marital status, alcohol use, occupation, cigarette use, educational level, HIV positive, having chronic medical illness, sexual violence, family member alcohol use, physically inactive were associated with depression and/or anxiety with p value less than 0.25. In multivariable multilevel logistic regression analysis sexually violated, having a chronic medical illness, being divorced and widowed, having a job, and HIV positive were associated with depression and/or anxiety with a p-value of less than 0.05. The development of depression and/or anxiety was 1.39 times more likely among divorced and widowed [AOR = 1.39; 95% CI: (1.14, 1.69)]. The odds of depression and/or anxiety development were 2.09 times higher among HIV-positive subjects than negative subjects [AOR = 2.09; 95% CI: (1.45, 3.02)]. Being sexually violated was 2.81 times higher than not experiencing sexual violence to have depression and/or anxiety [AOR = 2.81;95% CI: (2.05, 3.85)]. The odds of depression and/or anxiety development were 1.55 times higher among participants who have a job as compared with participants who have been between jobs [AOR = 1.55; 95% CI: (1.27, 1.90)]. The odds of experiencing depression and/or anxiety were 3.50 times higher among participants who have chronic medical illnesses compared to the others who haven’t chronic medical illnesses [AOR = 3.50; 95% CI: (2.89, 4.23)] (Table 3).

Discussion

The overall prevalence of depression and/or anxiety from the KDHS data was 3.84% with a 95% CI of (3.56,4.14). The prevalence of depression and/or anxiety conducted in this study is at a diagnostic level. The two most prevalent mental health conditions among the general population are depressive and anxiety disorders, and because of their terrible effects, there are major public health issues. The participants in this study were told by physicians they have depression and anxiety compared to other studies which were assessed by screening tools. This finding is in line with other studies conducted in Ethiopia 4.14% [33]. In other words, this finding is lower than studies conducted in Pakistan 27.4% [34], Nigeria 20.5% [35], and China 14.2% [36]. The main possible reason for this discrepancy could be the different measurement tools for instance Zung’s depression and anxiety self-rating scale screening tool was used but, our study was based on their diagnosis level told by the physician [36]. The other reason for this disparity can result from the sociocultural differences between the study participants.

Regarding factors associated with depression and/or anxiety was being sexually violated. This finding was concordant with other studies conducted in other countries United States [37,38] The probable reason for this association might be the effect of the emotional trauma of being violated that results in depression and or anxiety [37]. The other probable evidence for this association could be the impact of stigma from the other individual that leads to self-isolation and finally makes them anxious and/or depressed.

The other factor associated with depression and/or anxiety was having a chronic medical illness. This association is consistent with former studies conducted in the United States [39,40]. The probable reason for the association might be explained by dysregulation of specific Hypothalamic-pituitary-adrenocortical biological mechanisms, such as hemostasis of sympathetic nerve systems, which contribute to the pathophysiology of both physical and mental disorders [39]. The other reason for this association could be the disadvantages both at work and in private life that come from being unable to earn money for their needs [40]. There might be a bidirectional association that cannot be checked by a cross-sectional study physical illness can lead to mental disorders and vice versa.

Being divorced and widowed was the factor associated with depression and/or anxiety in Malaysia [17] and Ethiopia [33] likewise, this factor was also associated significantly. The reason for the associations could be because being divorced/ widowed had a psychological impact of loneliness isolation disconnect from social support [17]. Another evidence might be the effect of dependence that comes from maltreatment by others because no one has belonged to them for protection. Having a job was another factor associated with depression and/or anxiety. This is in line with former studies conducted in Ethiopia [33]. The possible reason for the association could be justified as people’s employment demands surpass their capacity for coping, which could lead to more stress risk of depression symptoms developing [33]. The other reason for the associations could be the effect of job-related stress which can persist for a prolonged time and lead to depression and/or anxiety.

Another factor that was associated with depression and/or anxiety was being HIV positive. This association was consistence with previous studies conducted in Ethiopia [41,42]. The possible reason for the association could be due to the psychological effect of receiving the diagnosis of HIV-positive, the stigma and emotional fallout might trigger a depressive and anxiety episode or relapse of the disorders [42]. The other possible evidence for the association could be the impact of HIV on losing their work, fear of being disregarded by others, and consequently difficulty in financial troubles [41]. The other evidence for this association might be the effect of the HAART drug and its side effects on the brain, the virus by itself, and the psychological effect of stigma/discrimination. Depression and anxiety are the most prevalent disorders with high public health burdens. This national finding could provide a clue for policymakers to mitigate depression and anxiety disorders. All concerned bodies; the Kenya National Health Office and other stakeholders are advised to mitigate the burden of depression and anxiety more than the effort used.

Limitations of the study

Although this study has many strengths, it also has limitations inherent to the cross-sectional study design. The other weakness of this study is recall bias and social desirability bias to inform they have depression and or anxiety.

Conclusions

The finding of this study revealed the actual diagnosis of depression and/or anxiety which is 3.84%. Sexually violated, having a chronic medical illness, being divorced and widowed, having a job, and being HIV positive were associated with depression and/or anxiety. The impact of depression and anxiety is a great health challenge that needs fast interventions to mitigate its global burden in Kenya. The Kenya policymakers and stakeholders are expected to reduce the risk factors of depression and/or anxiety especially sexual violations and HIV ADIS distributions.

Acknowledgment

We would like to ensure the MEASUR DHS who allowed to access this dataset to conduct this secondary data analysis.

Abbreviation

AIC

Akaike Information Criteria

AOR

Adjusted Odd Ratio

DHS

Demographic Health Data

CI

Confidence Interval

ICC

Intra-Class Correlation

MOR

Median Odds Ratio

PCV

Proportional Change in Variance

WHO

World Health Organizations

Data Availability

No.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Health Organization. Depression and other common mental disorders: global health estimates. World Health Organization, 2017. [Google Scholar]
  • 2.Widiger TA, Crego C. The purpose of this chapter is to consider the relationship of psychopathy with disorders included within the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association [APA], 2013). The co-occurrence of one disorder, such as psychopathy, with another disorder is often described as comorbidity (ie, the comorbid presence of two disorders). The term “comorbidity” made its first appearance in the title or abstract. Handbook of psychopathy. 2018:281. [Google Scholar]
  • 3.James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789-858. doi: 10.1016/S0140-6736(18)32279-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bansal P, Chaudhary A, Soni RK, Sharma S, Gupta VK, Kaushal P. Depression and anxiety among middle-aged women: A community-based study. J Family Med Prim Care. 2015;4(4):576–81. doi: 10.4103/2249-4863.174297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mirzaei M, Yasini Ardekani SM, Mirzaei M, Dehghani A. Prevalence of depression, anxiety and stress among adult population: results of Yazd health study. Iran J Psychiatry. 2019;14(2):137–46. [PMC free article] [PubMed] [Google Scholar]
  • 6.Saxena S, Funk M, Chisholm D. World health assembly adopts comprehensive mental health action plan 2013-2020. Lancet. 2013;381(9882):1970–1. doi: 10.1016/S0140-6736(13)61139-3 [DOI] [PubMed] [Google Scholar]
  • 7.American Psychiatric Association D, Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American psychiatric association; 2013. [Google Scholar]
  • 8.González-Mesa E, Kabukcuoglu K, Blasco M, Körükcü O, Ibrahim N, González-Cazorla A, et al. Comorbid anxiety and depression (CAD) at early stages of the pregnancy. A multicultural cross-sectional study. J Affect Disord. 2020;270:85–9. doi: 10.1016/j.jad.2020.03.086 [DOI] [PubMed] [Google Scholar]
  • 9.Goodwin RD, Weinberger AH, Kim JH, Wu M, Galea S. Trends in anxiety among adults in the United States, 2008–2018: Rapid increases among young adults. Journal of Psychiatric Research. 2020;130:441–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bhutta H. How Stress Affects Your Oral Health. Mental Health. 2023. doi: ValidDOIHere [Google Scholar]
  • 11.Liu X, Zhao W, Hu F, Hao Q, Hou L, Sun X, et al. Comorbid anxiety and depression, depression, and anxiety in comparison in multi-ethnic community of west China: prevalence, metabolic profile, and related factors. J Affect Disord. 2022;298(Pt A):381–7. doi: 10.1016/j.jad.2021.10.083 [DOI] [PubMed] [Google Scholar]
  • 12.Gwynn RC, McQuistion HL, McVeigh KH, Garg RK, Frieden TR, Thorpe LE. Prevalence, diagnosis, and treatment of depression and generalized anxiety disorder in a diverse urban community. Psychiatr Serv. 2008;59(6):641–7. doi: 10.1176/ps.2008.59.6.641 [DOI] [PubMed] [Google Scholar]
  • 13.Kilkkinen A, Kao-Philpot A, O’Neil A, Philpot B, Reddy P, Bunker S, et al. Prevalence of psychological distress, anxiety and depression in rural communities in Australia. Aust J Rural Health. 2007;15(2):114–9. doi: 10.1111/j.1440-1584.2007.00863.x [DOI] [PubMed] [Google Scholar]
  • 14.Behera P, Sharan P, Mishra AK, Nongkynrih B, Kant S, Gupta SK. Prevalence and determinants of depression among elderly persons in a rural community from northern India. Natl Med J India. 2016;29(3):129–35. [PubMed] [Google Scholar]
  • 15.Taheri Tanjanai P, Moradinazar M, Najafi F. Prevalence of depression and related social and physical factors amongst the Iranian elderly population in 2012. Geriatr Gerontol Int. 2017;17(1):126–31. doi: 10.1111/ggi.12680 [DOI] [PubMed] [Google Scholar]
  • 16.Goes VF, Wazlawik E, D’Orsi E, González-Chica DA. Severe obesity increases the prevalence but not the incidence of depressive symptoms in the elderly-population-based cohort in Southern Brazil. Int Psychogeriatr. 2017;29(8):1307–16. doi: 10.1017/S1041610216002246 [DOI] [PubMed] [Google Scholar]
  • 17.Lugova H, Andoy-Galvan JA, Patil SS, Wong YH, Baloch GM, Suleiman A, et al. Prevalence and associated factors of the severity of depression, anxiety and stress among low-income community-dwelling adults in Kuala Lumpur, Malaysia. Community mental health journal. 2021;1(1):1–10. [DOI] [PubMed] [Google Scholar]
  • 18.Ahmad A, Abujbara M, Jaddou H, Younes NA, Ajlouni K. Anxiety and depression among adult patients with diabetic foot: prevalence and associated factors. J Clin Med Res. 2018;10(5):411–8. doi: 10.14740/jocmr3352w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mirza I, Jenkins R. Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review. BMJ. 2004;328(7443):794. doi: 10.1136/bmj.328.7443.794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Amu H, Osei E, Kofie P, Owusu R, Bosoka SA, Konlan KD, et al. Prevalence and predictors of depression, anxiety, and stress among adults in Ghana: A community-based cross-sectional study. PLoS One. 2021;16(10):e0258105. doi: 10.1371/journal.pone.0258105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.de Castro F, Cappa C, Madans J. Anxiety and depression signs among adolescents in 26 low- and Middle-Income Countries: prevalence and association with functional difficulties. J Adolesc Health. 2023;72(1S):S79–87. doi: 10.1016/j.jadohealth.2022.03.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bante A, Mersha A, Zerdo Z, Wassihun B, Yeheyis T. Comorbid anxiety and depression: Prevalence and associated factors among pregnant women in Arba Minch zuria district, Gamo zone, southern Ethiopia. PLoS One. 2021;16(3):e0248331. doi: 10.1371/journal.pone.0248331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Im H, Swan LE, Warsame AH, Isse MM. Risk and protective factors for comorbidity of PTSD, depression, and anxiety among Somali refugees in Kenya. Int J Soc Psychiatry. 2022;68(1):134–46. doi: 10.1177/0020764020978685 [DOI] [PubMed] [Google Scholar]
  • 24.Hailemariam S, Tessema F, Asefa M, Tadesse H, Tenkolu G. The prevalence of depression and associated factors in Ethiopia: findings from the National Health Survey. Int J Ment Health Syst. 2012;6(1):23. doi: 10.1186/1752-4458-6-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Uljarević M, Hedley D, Rose-Foley K, Magiati I, Cai RY, Dissanayake C, et al. Anxiety and depression from adolescence to old age in autism spectrum disorder. J Autism Dev Disord. 2020;50(9):3155–65. doi: 10.1007/s10803-019-04084-z [DOI] [PubMed] [Google Scholar]
  • 26.Hamrah MS, Hamrah MH, Ishii H, Suzuki S, Hamrah MH, Hamrah AE, et al. Anxiety and depression among hypertensive outpatients in Afghanistan: a cross-sectional study in Andkhoy City. Int J Hypertens. 2018;2018:8560835. doi: 10.1155/2018/8560835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Khanzada FJ, Soomro N, Khan SZ. Association of physical exercise on anxiety and depression amongst adults. J Coll Physicians Surg Pak. 2015;25(7):546–8. [PubMed] [Google Scholar]
  • 28.Martinsen EW. Physical activity in the prevention and treatment of anxiety and depression. Nord J Psychiatry. 2008;62 Suppl 47:25–9. doi: 10.1080/08039480802315640 [DOI] [PubMed] [Google Scholar]
  • 29.Payne P, Crane-Godreau MA. Meditative movement for depression and anxiety. Front Psychiatry. 2013;4:71. doi: 10.3389/fpsyt.2013.00071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Adeoti AO, Dada M, Fadare J. Prevalence of depression and anxiety disorders in people living with HIV/AIDS in a tertiary hospital in South Western Nigeria. Medical Reports and Case Studies. 2018;3(1):1–5. [Google Scholar]
  • 31.James PB, Renzaho AMN, Mwanri L, Miller I, Wardle J, Gatwiri K, et al. The prevalence of anxiety, depression, and post-traumatic stress disorder among African migrants: A systematic review and meta-analysis. Psychiatry Res. 2022;317:114899. doi: 10.1016/j.psychres.2022.114899 [DOI] [PubMed] [Google Scholar]
  • 32.Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med. 2017;36(20):3257–77. doi: 10.1002/sim.7336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Deyessa N, Berhane Y, Alem A, Hogberg U, Kullgren G. Depression among women in rural Ethiopia as related to socioeconomic factors: a community-based study on women in reproductive age groups. Scand J Public Health. 2008;36(6):589–97. doi: 10.1177/1403494808086976 [DOI] [PubMed] [Google Scholar]
  • 34.Farooq S, Khan T, Zaheer S, Shafique K. Prevalence of anxiety and depressive symptoms and their association with multimorbidity and demographic factors: a community-based, cross-sectional survey in Karachi, Pakistan. BMJ Open. 2019;9(11):e029315. doi: 10.1136/bmjopen-2019-029315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Igbokwe CC, Ejeh VJ, Agbaje OS, Umoke PIC, Iweama CN, Ozoemena EL. Prevalence of loneliness and association with depressive and anxiety symptoms among retirees in Northcentral Nigeria: a cross-sectional study. BMC Geriatr. 2020;20(1):153. doi: 10.1186/s12877-020-01561-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Yin W, Pang L, Cao X, McGoogan JM, Liu M, Zhang C, et al. Factors associated with depression and anxiety among patients attending community‐based methadone maintenance treatment in C hina. Addiction. 2015;110:51-60. [DOI] [PubMed] [Google Scholar]
  • 37.Choudhary E, Smith M, Bossarte RM. Depression, anxiety, and symptom profiles among female and male victims of sexual violence. Am J Mens Health. 2012;6(1):28–36. doi: 10.1177/1557988311414045 [DOI] [PubMed] [Google Scholar]
  • 38.Lindert J, von Ehrenstein OS, Grashow R, Gal G, Braehler E, Weisskopf MG. Sexual and physical abuse in childhood is associated with depression and anxiety over the life course: systematic review and meta-analysis. Int J Public Health. 2014;59(2):359–72. doi: 10.1007/s00038-013-0519-5 [DOI] [PubMed] [Google Scholar]
  • 39.Bhattacharya R, Shen C, Sambamoorthi U. Excess risk of chronic physical conditions associated with depression and anxiety. BMC Psychiatry. 2014;14:10. doi: 10.1186/1471-244X-14-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhao G, Ford ES, Dhingra S, Li C, Strine TW, Mokdad AH. Depression and anxiety among US adults: associations with body mass index. Int J Obes (Lond). 2009;33(2):257–66. doi: 10.1038/ijo.2008.268 [DOI] [PubMed] [Google Scholar]
  • 41.Hankebo M, Fikru C, Lemma L, Aregago G. Depression and associated factors among people living with human immunodeficiency virus attending antiretroviral therapy in public health facilities, hosanna town, southern ethiopia. Depress Res Treat. 2023;2023:7665247. doi: 10.1155/2023/7665247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chaudhury S, Bakhla AK, Saini R. Prevalence, impact, and management of depression and anxiety in patients with HIV: a review. Neurobehavioral HIV Medicine. 2016:15–30. [Google Scholar]

Decision Letter 0

Kamalakar Surineni

26 Dec 2024

PONE-D-24-00891Determinants of depression and/or anxiety among the adult community in Kenya: Multilevel analysis of Kenya Demographic Health Survey of 2022PLOS ONE

Dear Dr.Mamaru Melkam Amsalu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by  Feb 09 2025 11:59PM, If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Kamalakar Surineni, MD, MPH

Guest Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

Additional Editor Comments (if provided):

As noted by the reviewers, the paper needs considerable improvements but it still holds value. Please address and resubmit for further consideration.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: I Don't Know

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As the reviewer, I have conducted a detailed assessment of the manuscript titled "Determinants of depression and/or anxiety among the adult community in Kenya: Multilevel analysis of Kenya Demographic Health Survey of 2022" using the STROBE Statement checklist for observational studies. Here is an in-depth report addressing each of the checklist items and providing specific line references where issues have been identified:

Title and Abstract:

1. (a) The title accurately indicates the study's design as a multilevel analysis of Kenya demographic health survey of 2022.

• But it was also better to put the specific statistical model like multilevel binary logistic regression analysis as a study design.

(b) The abstract did not effectively describe what was indicated the title.

• The study revealed the overall prevalence of depression and/or anxiety among the community in Kenya from Kenya Demographic and Health Survey data of 2022, but the title you indicated and the objective you described in the abstract are completely unrelated. So, how do you relate the title with that of line 29-30?

• Line 32-33 needs to be rewrite.

• Line 33-34 is better suited for only multilevel analysis, as it’s reasoned for both Multilevel and logistic regression is inappropriate. Because the clustering nature of the data is not a reason for both multilevel and binary logistic regression analysis.

• Line 35 “The overall prevalence of 3.84% with a 95% CI of (3.56, 4.14)”, Whose prevalence, is it? It needs to be corrected.

• Line 36 “In multivariant multilevel logistic regression”, what does that mean multivariant? How do you relate with the word “multivariate” and “multivariable”.

• The keywords (line 45) you indicated is not enough.

• Overall, the abstract is not effectively described what was done.

Introduction:

2. The introduction section presents several issues:

• Line 54 and line 60: DSM-5 and WHO need to be abbreviated at first.

• Line 91-98: font size is not similar with others.

• Line 97-98: “This study aims to determine the associated factors of depression and anxiety with their burden among adult communities in Kenya from Kenya Demographic and Health Survey data of 2022”, how do you relate with the indicated objective in the abstract part? Even with that of indicated title? What is the difference between “Determinants” and “associated factors”?

• The introduction lacks the prevalence of depression in Africa particularly in Keny and lacks relevant literature to establish the rationale.

• Overall, the introduction is poorly written.

Objectives:

3. The manuscript does not clearly state specific study objectives, which is a critical omission. Specific objectives should be explicitly defined, including any prespecified hypotheses.

Methods:

4. The manuscript accurately presents the key elements of the study design, appropriately considering it as a secondary data analysis.

5. The description of the setting, locations, and data collection dates is correctly provided.

6. Since this is a secondary data analysis, the absence of eligibility criteria and participant selection details is acceptable so I didn’t see such thing.

7. The dependent and independent variables are not well-defined. How do you measure your dependent variable? Even if, the dependent variable was used from the KDHS definitions as reported in 2022, you should have established its measurement with relevant literature or you can operationalize it as well. Mention its indictor.

8. While all independent variables of the study indicated, sources of data for each variable and their method of data collection are not mentioned. You should have to describe each independent variable.

9. Why Stata version 14? Why not 17?

10. The manuscript explains how quantitative variables were handled in the analyses, including the use of different analytical techniques. However, irrelevant sentences types are described (Lines 126-127), which should be removed.

11. The statistical methods, including multilevel logistic regression to control for potential confounding variables, are well-described. However, it is not indicated how missing data were analyzed.

Results:

12. There are several issues in the results section:

• Line 170:” deviation” how do you relate with that of deviance?

• The reference error "Error! Reference source not found" needs clarification.

• Missing data in baseline variables should be explained, along with the methods used to address the missing data.

• The manuscript should clarify the model fit statistics referenced in the text (Line 376). It is not clear how someone knows whether the given result is COR or AOR.

• While the third model contained community-level variables (Residence: lines 135-136), it is not statistically significant at 5% level of significance as presented in Table 3. So, do you think that multilevel analysis is suitable or appropriate statistical method for the given data set? Is it relevance?

Discussion:

13. The 'Discussion' section can be generally divided into 3 separate paragraphs. 1) Introductory paragraph/rationale of the study, 2) Intermediate paragraphs/compare and contrast with the most recent and relevant literature, 3) Concluding paragraph/indicating future directions. The introductory paragraph contains the main idea of performing the study question.

• While the manuscript mentions the large sample size as a strength indicating there is adequate power to detect the true effect of the independent variable. However, it does not provide a power calculation to support this claim.

• Some limitations are discussed, but the limitation related to the 24-hour recall for bias is not mentioned and there is potential social desirability bias that could impact on the results. Discuss finding should be interpreted with caution.

Recommendation

This comprehensive report outlines the issues identified throughout the manuscript, with specific line references and requires substantial major revisions to address these concerns and enhance the clarity, relevance, and presentation of results. After making the necessary major revisions with re-analysis of the data, a re-evaluation is recommended for considering publication.

Reviewer #2: Overall, the premise and intention of the research by the authors is notable. However, the research question appears to be limited. The paper only calculates the percentage of individuals who received a diagnosis of depression and anxiety by a physician, and this ultimately is too limited to be generalized as prevalence of these conditions in the general population. Taking this alone does not adequately answer the question of general prevalence in Kenya.

The research question also appears to be simply a calculation from a dataset. It would be beneficial to have a more involved research question that takes into account other factors either in addition to prevalence or factors influencing prevalence. Other potential factors that are listed (such as being sexually violated) appear to be seen by chance rather than postulated or hypothesized in the beginning. There does not appear to be a clear hypothesis from the authors in the beginning and this can make the findings appear random and incohesive in nature. The limitations of the study were also not clarified adequately. Lastly, there appears to be a lack of clarity in the English grammar at times.

Although the intention of the authors is commendable, and this is a good topic for research, the overall methodology and research question requires significant revision.

Reviewer #3: The study presents an insightful multilevel analysis of the determinants of depression and anxiety in Kenya using the Kenya Demographic Health Survey 2022 data. The strengths of the study are:

1. Addressing mental health issues in Kenya is significant, considering the limited number of studies in this area.

2. Using data from a nationally representative survey enhances the validity and generalizability of findings.

3. The use of multilevel logistic regression considers the clustering nature of the data, which is methodologically appropriate.

4. The study identifies critical determinants like sexual violence, chronic illness, HIV status, and marital status, which can guide interventions.

I have the following recommendations:

1. There are many grammatical errors and some sentences are disjointed. Would advise a recheck of the manuscript or use assistance of writing services.

2. The study design and data extraction methods are described but lack clarity regarding the tools used for measuring depression and anxiety. Provide details on how depression and anxiety were diagnosed (e.g., DSM criteria, specific screening tools).

3. The reported prevalence of 3.84% seems low compared to global studies, potentially underestimating the problem. Discuss the implications of relying on physician-diagnosed cases rather than standardized screening tools.

4. While statistical methods are robust, the discussion of model fit (AIC, BIC) and ICC is limited. Elaborate on these metrics to justify the selection of the final model.

5. The discussion relies heavily on previous studies without critically analyzing the study's unique findings. Expand the discussion to include potential cultural or systemic explanations for the identified associations.

6. Recommendations for interventions are broad and not Kenya-specific. Propose tailored policy measures considering Kenya's healthcare infrastructure and cultural context.

7. Reorganize the introduction to clearly define the study's objectives and significance.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Nikhil Tondehal

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer comments_plosOne.docx

pone.0319571.s001.docx (19.7KB, docx)
PLoS One. 2025 Mar 28;20(3):e0319571. doi: 10.1371/journal.pone.0319571.r003

Author response to Decision Letter 1


8 Jan 2025

Cover letter

Revision and resubmission of the manuscript with ID Number PONE-D-24-00891. Before all, I would like to thank the editorial teams on behalf of the authors, Plos One Journal regarding the fast review procedure of the manuscript titled “Prevalence and determinants of depression and/or anxiety among adults using Kenya Demographic and Health Survey of 2022: Multilevel logistic regression analysis” we thank you, for all the time and energy you devoted and the reviewers invested in offering feedback on our article, as well as for your constructive comments and suggestions. Lastly, we would like to confirm that this paper has not already been published or is not being considered by another journal for publication. All authors have approved the manuscript and agreed with its resubmission to Plos One Journal.

With regards!

On behalf of all the co-authors,

Mamaru Melkam, Correspondence author.

The authors have declared that no competing interests exist.

The authors received no specific funding for this work.

Response to the editor’s

We sincerely appreciate your constructive comments and suggestions for further improving our article. Based on your feedback and recommendations, we have made corrections and changes to the manuscript revising the whole part. Please find the point-by-point response to the reviewers' comments and recommendations below in blue color. The manuscript is amended in track change in a red color. Additionally, efforts were made to improve the language or typo errors to be simple for the understanding of readers.

Response to the reviewer's comments

On behalf of the authors, I'd like to express my gratitude to the editorial board, academic editor, and reviewers for your insightful comments that helped to increase the quality of the manuscript to become more scientifically sound. We thank all of the dear reviewers and editors for the constrictive comment to make our manuscript more improved. All the concerns raised by the reviewers and editor were tried to be addressed and the suggestions were also accepted. Currently, the article has undergone significant advancement as a result of the suggestions made by editing teams and reviewers from the initial submission to the present time. As you suggested, we have uploaded the track change and the cleaned revised manuscript.

Reviewer comments

Reviewer 1

As the reviewer, I have conducted a detailed assessment of the manuscript titled "Determinants of depression and/or anxiety among the adult community in Kenya: Multilevel analysis of Kenya Demographic Health Survey of 2022" using the STROBE Statement checklist for observational studies. Here is an in-depth report addressing each of the checklist items and providing specific line references where issues have been identified:

Response: Thank you very much for the comments and suggestions you provided to enhance the scientific quality of this manuscript to be easily understandable for the readers.

Title and Abstract:

1. (a) The title accurately indicates the study's design as a multilevel analysis of the kenya demographic health survey of 2022.

• But it was also better to put the specific statistical model like multilevel binary logistic regression analysis as a study design.

Response: Thank you for the comment; we have incorporated as you recommended.

(b) The abstract did not effectively describe what was indicated the title.

• The study revealed the overall prevalence of depression and/or anxiety among the community in Kenya from Kenya Demographic and Health Survey data of 2022, but the title you indicated and the objective you described in the abstract are completely unrelated. So, how do you relate the title with that of line 29-30?

Response: Thank you for the suggestion; we amended the abstract introduction part to be consistence with the title as you suggested.

• Line 32-33 needs to be rewrite.

Response: Thank you for the concerns; it is rewritten based on your recommendations.

• Line 33-34 is better suited for only multilevel analysis, as it’s reasoned for both Multilevel and logistic regression is inappropriate. Because the clustering nature of the data is not a reason for both multilevel and binary logistic regression analysis. Response: Thank you for the comment; it is refined as you suggested

• Line 35 “The overall prevalence of 3.84% with a 95% CI of (3.56, 4.14)”, Whose prevalence, is it? It needs to be corrected.

Response: Thank you for the suggestion; we made it the prevalence of depression and/or anxiety.

• Line 36 “In multivariant multilevel logistic regression”, what does that mean multivariant? How do you relate with the word “multivariate” and “multivariable”.

Response: Thank you for the comment; we have amended it as multivariable. The multivariate methods are not the same as multivariable methods. Multivariate methods have more than one dependent variable or place variables on an equal footing. Multivariable methods have one dependent variable and more than one independent variable or covariates.

• The keywords (line 45) you indicated is not enough.

Response: Thank you for the concern; we add more words.

• Overall, the abstract is not effectively described what was done.

Response: Thank you for the comment and suggestions we have made so much improvement on the abstract.

Introduction:

2. The introduction section presents several issues:

• Line 54 and line 60: DSM-5 and WHO need to be abbreviated at first.

Response: Thank you for the comment; they are correct as you suggested.

• Line 91-98: font size is not similar with others.

Response: Thank you for the suggestion; it is amended.

• Line 97-98: “This study aims to determine the associated factors of depression and anxiety with their burden among adult communities in Kenya from Kenya Demographic and Health Survey data of 2022”, how do you relate with the indicated objective in the abstract part? Even with that of indicated title? What is the difference between “Determinants” and “associated factors”?

Response: Thank you for the comment; we made the last paragraph of the introduction consistence with the abstract and title by making determinants.

• The introduction lacks the prevalence of depression in Africa particularly in Keny and lacks relevant literature to establish the rationale.

Response: Thank you for the concern; we have included more prevalence as you recommended.

• Overall, the introduction is poorly written.

Response: Thank you for the comment; we improved the entire introduction much better based on your comments.

Objectives:

3. The manuscript does not clearly state s/pecific study objectives, which is a critical omission. Specific objectives should be explicitly defined, including any prespecified hypotheses.

Response: Thank you for the comment; the aims or objectives of this study were mentioned in the abstract and introduction last paragraph, please take a look at manuscript line number (117,123).

Methods:

4. The manuscript accurately presents the key elements of the study design, appropriately considering it as a secondary data analysis.

5. The description of the setting, locations, and data collection dates is correctly provided.

6. Since this is a secondary data analysis, the absence of eligibility criteria and participant selection details is acceptable so I didn’t see such thing.

Response: Thank you for the comment; the eligibility criteria were the study participants who were not avail at home during the data collection period for this DHS data collection.

7. The dependent and independent variables are not well-defined. How do you measure your dependent variable? Even if, the dependent variable was used from the KDHS definitions as reported in 2022, you should have established its measurement with relevant literature or you can operationalize it as well. Mention its indictor.

Response: Thank you for the suggestion; DHS measures depression and anxiety based on the diagnostic criteria. Study participants leveled as they have depression and anxiety by physicians.

8. While all independent variables of the study indicated, sources of data for each variables and their method of data collection are not mentioned. You should have to describe each independent variable.

Response: Thank you for the comment; the data were collected through the interview-based survey method. The data were collected interview-based data collection for all independent variables.

9. Why Stata version 14? Why not 17?

Response: Thank you for the concern; because of we can’t access the updated version 17 for this analysis.

10. The manuscript explains how quantitative variables were handled in the analyses, including the use of different analytical techniques. However, irrelevant sentences types are described (Lines 126-127), which should be removed.

Response: Thank you for the suggestion; we have amended based on your suggestion.

11. The statistical methods, including multilevel logistic regression to control for potential confounding variables, are well-described. However, it is not indicated how missing data were analysed.

Response: Thank you for the comment; Missing values for the dependent variable were removed from this study. For the independent variables, the imputations method can be used for the missed data for determinant factors.

Results:

12. There are several issues in the results section:

• Line 170:” deviation” how do you relate with that of deviance?

Response: Thank you for the comment; we have conducted a deviance measurement among models which means deviation among the null model with each model. We have selected the best model with the lowest deviance.

• The reference error "Error! Reference source not found" needs clarification.

Response: Thank you for the concern; it is amended as you suggested.

• Missing data in baseline variables should be explained, along with the methods used to address the missing data.

Response: Thank you for the comment; the management of the missed value for the independent variables can be managed through the imputations method.

• The manuscript should clarify the model fit statistics referenced in the text (Line 376). It is not clear how someone knows whether the given result is COR or AOR.

Response: Thank you for the comment; we have used multivariable analysis which means all factors associated with the binary analysis with the outcome variables that indicate the odd ratio is AOR.

• While the third model contained community-level variables (Residence: lines 135-136), it is not statistically significant at 5% level of significance as presented in Table 3. So, do you think that multilevel analysis is suitable or appropriate statistical method for the given data set? Is it relevance?

Response: Thank you for the comment; we have included other community-level variable mass media exposure but both are not associated. We conducted this study by considering community-level variables by hypothesizing they might be important with a huge sample size analysis but the community variable may not be necessarily associated.

Discussion:

13. The 'Discussion' section can be generally divided into 3 separate paragraphs. 1) Introductory paragraph/rationale of the study, 2) Intermediate paragraphs/compare and contrast with the most recent and relevant literature, 3) Concluding paragraph/indicating future directions. The introductory paragraph contains the main idea of performing the study question.

Response: Thank you for the comment; we have tried to incorporate the points you have raised in the discussion including the rationale, compression, and conclusion.

• While the manuscript mentions the large sample size as a strength indicating there is adequate power to detect the true effect of the independent variable. However, it does not provide a power calculation to support this claim.

Response: Thank you for the comment; the calculated sample size for this topic is under 400 which is not comparable but we omit the strength from this study since strength is not that much mandatory.

• Some limitations are discussed, but the limitation related to the 24-hour recall for bias is not mentioned and there is potential social desirability bias that could impact on the results. Discuss finding should be interpreted with caution.

Response: Thank you for the suggestion; it is improved based on your suggestions.

Recommendation

This comprehensive report outlines the issues identified throughout the manuscript, with specific line references and requires substantial major revisions to address these concerns and enhance the clarity, relevance, and presentation of results. After making the necessary major revisions with re-analysis of the data, a re-evaluation is recommended for considering publication.

Response: Thank you for the comment and suggestion; we improved the entire manuscript to enhance the quality and to make it clear.

Reviewer #2: Overall, the premise and intention of the research by the authors is notable. However, the research question appears to be limited. The paper only calculates the percentage of individuals who received a diagnosis of depression and anxiety by a physician, and this ultimately is too limited to be generalized as prevalence of these conditions in the general population. Taking this alone does not adequately answer the question of general prevalence in Kenya. The research question also appears to be simply a calculation from a dataset. It would be beneficial to have a more involved research question that takes into account other factors either in addition to prevalence or factors influencing prevalence.

Response: Thank you for the comment; we have used the diagnosis criteria to get severe depression and anxiety since there are many studies conducted with screening tools in the world. This study provides a nationwide real diagnosis with DSM-V which is novel and not well studied so far.

Other potential factors that are listed (such as being sexually violated) appear to be seen by chance rather than postulated or hypothesized in the beginning. There does not appear to be a clear hypothesis from the authors in the beginning and this can make the findings appear random and incohesive in nature.

Response: Thank you for the concern; sexual violence has been associated among many studies with depression and anxiety. It was not random we have conducted this study with the stated aim of a national dataset of DHS; the national data is intentionally collected for such kind of study as far as we know.

The limitations of the study were also not clarified adequately. Lastly, there appears to be a lack of clarity in the English grammar at times.

Response: Thank you for the suggestion; we have improved based on your suggestion.

Although the intention of the authors is commendable, and this is a good topic for research, the overall methodology and research question requires significant revision.

Response: Thank you for the suggestion and comments you provided; we have improved this manuscript a lot to be clear for the readers.

Reviewer #3: The study presents an insightful multilevel analysis of the determinants of depression and anxiety in Kenya using the Kenya Demographic Health Survey 2022 data. The strengths of the study are:

1. Addressing mental health issues in Kenya is significant, considering the limited number of studies in this area.

2. Using data from a nationally representative survey enhances the validity and generalizability of findings.

3. The use of multilevel logistic regression considers the clustering nature of the data, which is methodologically appropriate.

4. The study identifies critical determinants like sexual violence, chronic illness, HIV status, and marital status, which can guide interventions.

Response: Thank you for the comments and suggestions that you raised which are really important to enhance the scientific quality of this manuscript to be easily understandable for the readers.

I have the following recommendations:

1. There are many grammatical errors and some sentences are disjointed. Would advise a recheck of the manuscript or use assistance of writing services.

Response: Thank you for the comment; the typo and grammatical errors were checked by English language and mental health experts

Attachment

Submitted filename: Response to Reviewers.docx

pone.0319571.s003.docx (35.5KB, docx)

Decision Letter 1

Kamalakar Surineni

5 Feb 2025

Prevalence and determinants of depression and/or anxiety among adults using Kenya Demographic and Health Survey of 2022: Multilevel logistic regression analysis

PONE-D-24-00891R1

Dear Dr. Mamaru Melkam Amsalu, 

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kamalakar Surineni, MD, MPH

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you so much for improving the manuscript based on the reviewer feedback. I'm pleased to share that the manuscript now meets the publication criteria, and I’m happy to announce that it has been accepted!

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Abdu Hailu Shibeshi

Reviewer #3: Yes:  Nikhil Tondehal

**********

Acceptance letter

Kamalakar Surineni

PONE-D-24-00891R1

PLOS ONE

Dear Dr. Amsalu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kamalakar Surineni

Guest Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Reviewer comments_plosOne.docx

    pone.0319571.s001.docx (19.7KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0319571.s003.docx (35.5KB, docx)

    Data Availability Statement

    No.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES